Gerresheimer is a major drug delivery device and primary packaging company. Its products include insulin pens, inhalers, prefillable syringes, pharma plastic containers, and glass ampoules, vials, and cartridges. Gerresheimer Bünde is its centre of excellence for glass prefillable syringes and cartridges.
Associated CompaniesSensile Medical
Gerresheimer is a major supplier of speciality glass and plastic products to the healthcare sector, in particular pharma, and with a strong presence in parenteral delivery devices. The business comprises divisions: Plastics & Devices or Primary Packaging Glass.
The product portfolio of the Plastics & Devices Division includes insulin pens, inhalers, prefillable syringes, and pharmaceutical plastic containers for liquid and solid medicines with closure and safety systems. The Primary Packaging Glass Division produces glass primary packaging for medicines and cosmetics, such as ampoules, injection vials, and cartridges. Both divisions also supply products to the cosmetics sector as well as healthcare.
Gerresheimer AG is a public company, traded on the Frankfurt Stock Exchange (Symbol: GXI). It has worldwide operations and about 10,000 employees. It manufactures products in local markets, close to its customers. Revenues are approximately €1.4 billion.
PRODUCTION SITE BÜNDE
Gerresheimer Bünde is the company’s centre of excellence for prefillable glass syringes and glass cartridges. The prefillable glass syringes can be delivered as bulk goods (Gx® bulk) or in “ready-to-fill” format (Gx RTF®). For demanding, sensitive medications and high-viscosity agents Gerresheimer offers its customers prefillable plastic syringes made of cyclo olefin polymer (COP), the Gx RTF® ClearJect® and ClearJect® brands.